Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. MU
3. FDX
4. SPY
5. META
6. ABBV
7. ACN
8. NVDA
9. BLZE
10. IBM

Go back to Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 33.21 --0 (-0%)
Previous Close $33.21    52 Week High $66.55 
Open $33.21    52 Week Low $37.82 
Day High $33.21    P/E N/A 
Day Low $33.21    EPS $0.00 
Volume 3,890       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 33.21 --0 (-0%)
Previous Close $33.21    52 Week High $66.55 
Open $33.21    52 Week Low $37.82 
Day High $33.21    P/E N/A 
Day Low $33.21    EPS $0.00 
Volume 3,890